Global Kinetics’ Personal KinetiGraph (PKG), a wearable device for Parkinson’s disease patients, provided more information about symptoms than a routine clinic visit, a recent study found.
The device, which monitors, quantifies and reports Parkinson’s movement symptoms, generated new data that was significant enough to change the medical management of one-third of study participants, according to the company. The study was reported in the Journal of Parkinson’s Disease and was conducted at the Parkinson’s Institute and Clinical Center in Mountain View, Calif., from December 2015 through July 2016.
At DeviceTalks Boston, Tyler Shultz will give attendees an inside look at Theranos and how he was able to sound the alarm after he realized the company was falling apart. Shultz will take attendees behind the story that everyone is talking about: the rise and fall of Elizabeth Holmes and her diagnostic company, Theranos.
Join Shultz and 1,000+ medical device professionals at the 8th annual DeviceTalks Boston.